Abstract. Increasing evidence indicates that potassium (K + ) channels play important roles in the growth and development of human cancer. In the present study, we investigated the contribution of and the mechanism by which K + channels control the proliferation and tumor development of U87-MG human glioma cells. A variety of K + channel blockers and openers were used to differentiate the critical subtype of K + channels involved. The in vitro data demonstrated that selective blockers of voltage-gated K + (K V ) channels or ATP-sensitive K + (K ATP ) channels significantly inhibited the proliferation of U87-MG cells, blocked the cell cycle at the G 0 /G 1 phase and induced apoptosis. In the U87-MG xenograft model in nude mice, K V or K ATP channel blockers markedly suppressed tumor growth in vivo. Furthermore, electrophysiological results showed that K V or K ATP channel blockers inhibited K V /K ATP channel currents as well as cell proliferation and tumor growth over the same concentration range. In contrast, iberiotoxin, a selective blocker of calcium-activated K + channels, had no apparent effect on the cell proliferation, cell cycle or apoptosis of U87-MG cells. In addition, the results of fluorescence assays indicated that blockers of K V or K ATP channels attenuated intracellular Ca
Introduction
Gliomas are the most common malignant brain tumors and are characterized by relentless growth and aggressive invasion into the brain parenchyma (1) . Under the current standard of care, the life expectancy of patients with glioma is ~14 months after diagnosis despite aggressive surgery, radiation and chemotherapies (2) . Therefore, a better understanding of the mechanism through which glioma develops is necessary for efficient and specific inhibition of the progression of this form of cancer.
Potassium (K + ) channels are the most diverse ion channels in the plasma membrane (3) . Over the last 10 years, accumulating evidence has indicated that diverse types of K + channels, including voltage-gated, calcium-activated, two-pore domain and inward rectifier K + channels, are overexpressed in a number of tumor types, such as prostate, colon and breast (4) (5) (6) . Most previous studies have demonstrated that, in addition to controlling physiological parameters, K + channels also play important roles in the onset, proliferation and malignant progression of various types of cancer (7) . However, mammalian cells constitutively express an array of various types of K + channels. Although most previous studies have described the expression of a particular type of K + channel in a cancer cell line and have correlated the expression and functional activity of the channel with proliferation, it is not clear to what degree these individual K + channels contribute to proliferation or whether a specific association exists between particular K + channel subtypes and proliferation. Moreover, the mechanisms by which these K + channels facilitate cell proliferation remain obscure.
Increasing evidence has demonstrated that a variety of K + channels, such as voltage-gated K + channels (K V ), calciumactivated K + channels (K Ca ) and ATP-sensitive K + channels (K ATP ) (8) (9) (10) , are overexpressed in glioma biopsies and cultured cells. A previous study found a correlation between the activity of K ATP channels and proliferation of glioma cells and xenografted tumors (8) . However, it remains uncertain whether other K + channels are also proliferative molecules in glioma cells. Identification of K + channels that play a role in glioma growth may provide novel therapeutic targets. In the present study, we attempted to identify K + channels that affect the growth of human glioma U87-MG cells in vitro and in vivo. Using a variety of K + channel blockers and openers, we found that K V and K ATP channels play roles in controlling cell proliferation and tumorigenesis, whereas other K + channel subtypes do not. We also analyzed the mechanism of action of K + channels in cell proliferation by studying the relationship between K + channel activities and Ca 2+ entry with the use of MTT proliferation assay. A modified MTT assay was used to examine the effect on cell proliferation. Briefly, cells were seeded in a 96-well plate at 5,000 cells/well and incubated overnight. After drug treatment for 48 h, 20 µl of MTT solution (5 mg/ml) was added to each well, and the samples were incubated for an additional 4 h. Subsequently, the supernatant was removed, and the cells were dissolved in 150 µl of DMSO. Finally, absorbance was measured at 570 nm using a 96-well microplate reader (Thermo Scientific, USA).
Annexin V-FITC/PI apoptosis assay. Cells were double stained using an Annexin V-FITC/PI apoptosis detection kit. Briefly, after exposure to different drugs for 48 h, the cells were harvested, washed twice with cold PBS and resuspended in Annexin V binding buffer. Then, 5 µl of FITC-labeled Annexin V and 5 µl of PI were added. The cells were incubated for 15 min at room temperature in the dark with gentle oscillation. After the addition of 200 µl of binding buffer to each tube, the cells were analyzed within 1 h using a flow cytometer (Becton-Dickinson, USA).
Cell cycle assay. Cells were detached by trypsinization, seeded at 5x10 5 cells/well in a 6-well plate and incubated overnight. The cells were then treated with various drugs at different concentrations. Subsequently, the cells were harvested into cold PBS at different time points, fixed in ice-cold 70% ethanol and stored at 4˚C overnight for subsequent cell cycle analysis. Fixed cells were washed twice with PBS and resuspended in 1 ml of the staining reagents (100 µg/ml RNase A and 50 µg/ml PI). The samples were incubated in the dark for 30 min, and the distribution of cells in the various phases of the cell cycle was measured by flow cytometry.
[Ca 2+
] i measurements. Cells were grown overnight, washed twice with Hank's balanced salt solution (HBSS) and loaded with 1 µmol/l Fluo3-AM for 30 min in the dark at room temperature. Then cells were washed twice with Ca 2+ -free HBSS, re-suspended in Ca 2+ -free HBSS and incubated at room temperature for 20 min in the dark. When appropriate, the cells were pretreated with K + channel blockers or openers for 5 min before the initiation of Ca 2+ influx. Ca 2+ influx was measured as changes in fluorescent signals, which were recorded using a fluorescence microscope (Olympus, Japan) and analyzed using Matlab software.
In vivo therapy experiments. To further verify the antiproliferative efficacies of K + channel blockers, an in vivo experiment was performed using 6-to 8-week old nude mice. The nude mice were randomly divided into control and treated groups. The treated groups were subcutaneously injected with a suspension of 5x10 6 U87-MG cells with 4-AP (5 mmol/l), TEA (20 mmol/l) or glibenclamide (200 µmol/l), and mice in the control group were injected with a suspension of 5x10 6 cells with 0.01 mol/l PBS (8) . Tumor size was measured every 3 days and tumor volume was determined by calculating (length x width) 2 /2. At the end of the experiment, tumors were excised and weighed. A tumor growth curve was plotted according to the tumor volume, and the inhibitory rates of tumor growth were calculated according to the tumor weight. All procedures were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Electrophysiological assay. Membrane currents were recorded using a whole-cell voltage clamp and borosilicate glass pipettes (outer diameter, 1.5 mm; direct current resistance, 3-6 MΩ) constructed using a two-step puller (P-97; Sutter, USA). To investigate the K V currents, the pipette solution consisted of (in mmol/l) KCl 140, MgCl 2 2.5, HEPES 10, EGTA 11 and ATP 5 and the pH was adjusted to 7.2 (11). To investigate the K ATP currents, the micropipettes were filled with (in mmol/l) KCl 140, MgCl 2 1, ATP 0.01, EGTA-KOH 5 and HEPES-KOH 5 and the pH was adjusted to 7.3 (12) . The cells were bathed in an extracellular solution containing (in mmol/l) NaCl 135, KCl 5.4, MgCl 2 1.0, NaH 2 PO 4 0.33, CaCl 2 1.8, HEPES 10 and D-glucose 10 with 1 µmol/l TTX. The osmolarity was adjusted to 330 mOsm/l with sucrose and the pH was adjusted to 7.4. Whole-cell patch clamp recordings were performed at room temperature using a patch clamp amplifier (Axon-200B) (13) . Adjustments of capacitance compensation and series resistance compensation were performed before the membrane currents were recorded. The membrane currents were filtered at 10 kHz (-3 dB) and the data were processed using Clampfit (Axon, USA).
Statistical analysis. The data are expressed as the means ± standard error (± SE). Statistical significance was assessed using analysis of variance (ANOVA). P-values of <0.05 were considered to indicate statistically significant results.
Results

Effects of K
+ channel blockers and openers on cell proliferation. To identify the K + channels that affect U87-MG cell prolifera-tion, we used a variety of K + channel blockers and openers and an MTT assay was used to determine the number of live cells remaining after the drug treatment. Among the blockers, 4-AP and TEA are transient outward and delayed rectifier K V channel blockers, respectively (14) , whereas glibenclamide is a specific blocker of K ATP channels, and iberiotoxin is a specific K Ca channel blocker. As shown in Fig. 1 , cell proliferation was significantly inhibited by 4-AP and TEA in a dose-dependent manner and glibenclamide also significantly decreased the U87-MG cell number. However, 100 nmol/l iberiotoxin, a concentration that completely blocks K Ca channels (15) , only moderately inhibited U87-MG cell proliferation. Meanwhile, diazoxide, an opener of K ATP channels and phloretin, an opener of K Ca channels, had no significant effects on cell proliferation. Taken together, these data reveal that K V and K ATP channels but not K Ca channels have important roles in the proliferation of U87-MG cells.
+ channel blockers and openers on the cell cycle distribution. To elucidate the mechanisms through which K + channels influence the proliferation of glioma cells, flow cytometry was performed to investigate whether the U87-MG cell cycle may be influenced by various K + channel blockers or openers. As shown in Fig. 2A and B, the percentage of U87-MG cells in the G 0 /G 1 phase was significantly enhanced after exposure to 4-AP, TEA and glibenclamide for 48 h, whereas the percentage of cells in the S phase was markedly reduced. Iberiotoxin had no obvious effect on the U87-MG cell cycle at a concentration of 25 nmol/l. Meanwhile, activating K ATP channels with diazoxide and activating K Ca channels with phloretin increased the percentage of U87-MG cells in the S phase. These results were consistent with previous reports (16) that K + channels are believed to facilitate progression through G 1 /S checkpoint.
+ channel blockers and openers on cell apoptosis. To determine whether the reduction in cell viability caused by K + channel blockers was related to apoptotic cell death, the effects of different K + channel blockers and openers on U87-MG cell apoptosis were studied using Annexin V-FITC/PI staining. As illustrated in Fig. 2C , the percentage of Annexin V-FITCpositive apoptotic cells was increased by adding 4-AP or glibenclamide to the U87-MG cells (5.1±0.8% of control, 44.7±3.8% of 5 mmol/l 4-AP and 18.3±1.32% of 200 µmol/l glibenclamide). However, 4-AP only slightly increased necrosis, whereas glibenclamide induced noticeable necrosis (1.8±0.26% of control, 3.2±0.26% of 5 mmol/l 4-AP and 24.8±3.08% of 200 µmol/l glibenclamide). In contrast, at some of the tested concentrations, treatment with TEA, iberiotoxin, phloretin or diazoxide for 48 h had no apparent effect on cell apoptosis.
+ channel blockers and openers on Ca 2+ influx. To further explore the mechanism of K + channel involvement in U87-MG cell proliferation, we examined the effects of different K + channel blockers and openers on Ca 2+ influx. Ca 2+ influx was induced by the addition of 0.5 mmol/l CaCl 2 to the bathing medium (Ca 2+ -free HBSS), which caused a rapid increase in cytosolic Ca 2+ to a level that was sustained for several minutes. As shown in Fig. 3 Therapeutic efficacy of K + channel blockers. To provide direct evidence that K V or K ATP channels are responsible for tumor development, the antitumor activities of K V or K ATP channel blockers were investigated in nude mice with established human glioma U87-MG xenografts. As shown in Fig. 4A , U87 xenografts grew rapidly in mice, and the tumor size in the control group reached 1189.2±203.3 mm 3 over the duration of the experiment (27 days). Statistically, there were significant differences in both tumor volume and weight between the control and the treated groups. Mice treated with 4-AP at 5 mmol/l and glibenclamide at 200 µmol/l showed inhibition rates of 46.2 and 43.8%, respectively, which were significant (P<0.01) when compared with the control. TEA at 20 mmol/l suppressed tumor growth by 33.7% (P<0.05). The actual tumor weights at the time of sacrifice are shown in Fig. 4B . No obvious toxic effects were observed in any of the groups during the experiment. These results suggest that K V and K ATP channels play important roles in glioma development in vivo.
+ channel blockers on K + currents. To determine whether K + channel blockers inhibits cell proliferation and tumorigenesis via blockage of whole-cell K + currents, we next studied the dose-dependent effects of these three blockers on K V /K ATP currents in U87-MG cells. Representative recordings of the K V currents (transient and persistent K + currents) were evoked with a step-up depolarization protocol. Briefly, the membrane potential was pre-hyperpolarized from -50 mV to -110 mV for 100 msec, depolarized from -50 to +60 mV (10 mV increment/step, duration 200 msec) and subsequently restored to the original depolarizing potential of -50 mV (Fig. 5A) . Depolarizing the voltage from -110 to -50 mV and maintaining the level of -50 mV for 100 msec inactivated transient K + currents and a further depolarization voltage step from -50 to +60 mV evoked persistent K + currents (Fig. 5B) . The transient component (Fig. 5C ) was then visualized in isolation using point-by-point subtraction of the persistent component (as shown in Fig. 5B ) from the total outward current (as shown in Fig. 5A ). As shown in Fig. 5D , 5 mmol/l TEA remarkably inhibited the persistent outward currents and the persistent component was reduced completely after the application of TEA (40 mmol/l). Meanwhile, 4-AP (1 mmol/l) markedly suppressed the transient outward current and 4-AP (10 mmol/l) completely and reversibly blocked the transient components in each cell examined (Fig. 5E) .
To examine the effect of glibenclamide on K ATP currents, K ATP currents were activated by using standard whole cell recording with a pipette solution containing only 10 mmol/l ATP (12) . The membrane potential was normally held at -40 mV and the currents were evoked by a series of 400 msec depolarizing and hyperpolarizing current steps (-100 mV to +80 mV in 20 mV steps, Fig. 5F ). As shown in Fig. 5G , the whole-cell K + currents observed with low intracellular ATP were inhibited by extracellular glibenclamide (300 µmol/l). These data suggest that these three K + channel blockers have the same working concentration range for inhibiting K V /K ATP currents, cell proliferation and tumor growth, indicating that the effects of 4-AP, TEA and glibenclamide are indeed mediated by blockage of K + channels.
Discussion
As a crucial cellular function, cell growth is strictly controlled by several independent mechanisms. Since the pioneering study in lymphocytes by DeCoursey et al (17) , accumulating evidence has indicated that K + channels are relevant players in the control of this process. Diverse types of K + channels have been shown to be overexpressed in tumorous tissues and the roles of K + channels in tumor cell growth have been demonstrated (9, 15) . However, the types of K + channels involved in this process vary (18, 19) . For example, K Ca channels were found to be involved in prostate (5), gastric (20) and colorectal cancer (4) . In other tumors, proliferation was supported by K ATP channels or two-pore (2P)-domain channels (21, 22) . Nevertheless, in the majority of cancer cells, K V channels were correlated with proliferation (7, 16, 23) . It remains unknown why different types of K + channels induce proliferation in different cancer models.
In the present study, we showed that 4-AP, TEA and glibenclamide significantly suppressed cell proliferation in vitro. The percentage of U87-MG cells in the G 0 /G 1 phase was also significantly enhanced after exposure to 4-AP, TEA or glibenclamide for 48 h. On the other hand, diazoxide and phloretin increased the percentage of cells in the S phase. These findings, together with previous reports (8, 24) , demonstrate that Given the important role of K + channels in tumors, it is necessary to clarify their role in proliferation. One hypothesis is that K + channels keep the resting membrane potential sufficiently polarized to allow the influx of Ca 2+ via membrane ion channels (25) , implying that blocking K + channels will directly modulate Ca 2+ entry in malignant cells. This may be a partial reason for the induction of tumor growth via the abnormal expression of K + channel subtypes since Ca 2+ acts as an activator involved in many cellular signal transduction pathways, including the cell growth and mitosis pathways (26 The expression of K Ca channels is correlated with glioma malignancy, with higher levels of K Ca protein observed in more malignant glioma biopsy samples (27) . However, the relationship between K Ca channels and glioma cells is controversial. Some recent publications have proposed the idea that K Ca channels may have antiproliferative and antitumorigenic properties (28) . Other results implicating K Ca channels in the control of glioma cell growth have been collected using specific cell growth conditions, such as an elevated extracellular K + concentration (29) or serum deprivation (30) . Our data showed that the inhibitory effect of iberiotoxin was only observable at concentrations greatly exceeding those necessary for complete channel blockage (15) , and increases in apoptotic cells and cells in the G 0 /G 1 phase were not clearly observed, suggesting that K Ca channels may not play a role in the growth of U87-MG glioma cells in vitro.
Although all the blockers of K V and K ATP channels tested in this study suppressed glioma cell proliferation and tumor development, it remains unclear whether their effects occur at the concentrations required to block K + channel activities. Electrophysiological results showed that 4-AP, TEA and glibenclamide inhibited cell proliferation and tumor growth in the concentration range required to block K V /K ATP channel currents, indicating that these K + channel blockers suppress glioma cell proliferation by blocking K + channel activities and providing further support for the roles of K V /K ATP channels in mediating cell proliferation and tumor growth.
In summary, the present findings provide strong evidence that K V and K ATP channel blockers inhibit proliferation and tumorigenesis of U87-MG glioma cells. It is likely that K + channel activities modulate Ca 2+ influx into U87-MG cells and therefore affect the proliferation, cell cycle progression and apoptosis of these cells. Further study is needed to define the precise mechanisms responsible for the antiproliferative effects of pharmacological blockers of K V and K ATP channels. In any case, it is worthwhile to further explore the possibility of using K V and K ATP channels as new anti-glioma targets in the coming years.
